Search research articles
Contact Us
Filters
Showing results (501-510 of 538) with videos related to
Page
of 54
Sort By:
Leukemia & Lymphoma
|
April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
Katja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.
American Journal of Hematology
|
October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
Yves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
June 14, 2023
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Transplantation and Cellular Therapy
|
September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Firoozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
British Journal of Haematology
|
April 28, 2022
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT
Donal P McLornan, Luuk Gras, Ivonne Martin, et al.
Translational Psychiatry
|
September 20, 2017
Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomes
M L Alosco, A B Kasimis, J M Stamm, et al.
Bone Marrow Transplantation
|
May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
October 8, 2021
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Leopold Sellner, Johannes Schetelig, Linda Koster, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 538) with videos related to
Sort By:
Page
of 54
Leukemia & Lymphoma
|
April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
Katja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.
American Journal of Hematology
|
October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
Yves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
June 14, 2023
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Transplantation and Cellular Therapy
|
September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Firoozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
British Journal of Haematology
|
April 28, 2022
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT
Donal P McLornan, Luuk Gras, Ivonne Martin, et al.
Translational Psychiatry
|
September 20, 2017
Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomes
M L Alosco, A B Kasimis, J M Stamm, et al.
Bone Marrow Transplantation
|
May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
October 8, 2021
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Leopold Sellner, Johannes Schetelig, Linda Koster, et al.
Page
of 54